Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/jcm10061268
Keywords
oxidative stress; endoplasmic reticulum stress; antioxidant therapies; rare respiratory diseases; Alpha-1 antitrypsin deficiency; idiopathic pulmonary fibrosis; cystic fibrosis; primary ciliary dyskinesia
Categories
Funding
- Sociedad Valenciana de Neumologia
- ISCIII [PI17/01250]
- European Regional Development Funds
- FP Dual GVA Program
- GVA [ACIF/2019/231]
Ask authors/readers for more resources
Rare respiratory diseases like AATD, IPF, CF, and PCD have been shown to exhibit oxidative stress and endoplasmic reticulum stress. This review discusses their involvement in the pathologies and the potential use of antioxidants as therapeutic agents to mitigate the effects of oxidative stress.
Several studies have shown that some rare respiratory diseases, such as alpha-1 antitrypsin deficiency (AATD), idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), and primary ciliary dyskinesia (PCD) present oxidative stress (OS) and endoplasmic reticulum (ER) stress. Their involvement in these pathologies and the use of antioxidants as therapeutic agents to minimize the effects of OS are discussed in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available